| Literature DB >> 31905725 |
Hosam O Elansary1,2,3, Agnieszka Szopa4, Marta Klimek-Szczykutowicz4, Karolina Jafernik4, Halina Ekiert4, Eman A Mahmoud5, Ahmed Abdelmoneim Barakat6, Diaa O El-Ansary7.
Abstract
Discovering new natural resources of polyphenols is the aim of many recent studies in the field of natural product research. This study tentatively investigated the polyphenols profile of the stems of seven Mammillaria species (M. rhodantha, M. spinosissima, M. hahniana, M. crucigera, M. candida, M. albilanata, and M. muehlenpfordtii) using high performance liquid chromatography with DAD detector (HPLC-DAD) method. Furthermore, the anti-cancer, anti-oxidant, and anti-bacterial potentials of these extracts as well as major identified phenols were explored. The HPLC-DAD study confirmed the availability of six phenolic acids, including gentisic acid, chlorogenic acid, caffeic acid, protocatechuic acid, sinapic acid, and p-hydroxybenzoic acid. The dominant compounds were: gentisic acid in M. rhodantha and M. spinosissima; chlorogenic acid in M. muehlenpfordtii, M. crucigera, and M. rhodantha; and caffeic acid in M. rhodantha, M. crucigera, and M. spinosissima. Stems of Mammillaria sp. showed antiproliferative effects against HeLa, MCF-7, and Jurkat cells. In HeLa and MCF-7 cells, the best antiproliferative activities were found in the treatments with M. rhodantha, M. spinosissima, and M. muehlenpfordtii. The apoptotic assay of M. rhodantha, M. spinosissima, and M. muehlenpfordtii showed accumulation of necrotic cells in the early and late apoptotic phase. M. rhodantha, M. spinosissima, and M. muehlenpfordtii showed the highest anti-oxidant activities using 2,2-diphenyl-1-picrylhydrazyl (DPPH), β-carotene bleaching, and ferric reducing anti-oxidant power (FRAP) assays. M. rhodantha was the best source of antioxidants. Mammillaria sp. showed moderate anti-bacterial effects against bacteria and the highest effects were found using the extracts of M. rhodantha, M. spinosissima, M. crucigera and M. muehlenpfordtii against most bacteria. The anti-bacterial activities were attributed to other phenolic compounds (e.g., chlorogenic acid) than gentisic acid, which was not active against most bacteria. Mammillaria sp. could be considered to be an important natural source of phenolic acids with anti-cancer, anti-bacterial, and anti-oxidant activities.Entities:
Keywords: Mammillaria; anti-bacterial; anti-cancer; anti-oxidant; cytotoxicity; phenolic acids; stem extract
Mesh:
Substances:
Year: 2019 PMID: 31905725 PMCID: PMC6982789 DOI: 10.3390/molecules25010131
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The quantitative (mg 100 g−1 DW ± SD) estimations of phenolic acids in Mammillaria sp. stem extracts.
| Protocatechuic | Gentisic | Chlorogenic | p-Hydroxy-Benzoic | Caffeic | Sinapic | |
|---|---|---|---|---|---|---|
|
| 4.16 ± 0.44 | 38.24 ± 4.18 | 10.37 ± 1.06 | 2.64 ± 0.21 | 15.80 ± 1.67 | 3.07 ± 0.35 |
|
| 4.20 ± 0.40 | 40.44 ± 4.62 | 6.23 ± 0.63 | 0.96 ± 0.09 | 9.66 ± 0.94 | 7.88 ± 0.76 |
|
| 3.90 ± 0.31 | 5.63 ± 0.58 | 8.61 ± 0.82 | 1.47 ± 0.14 | 6.38 ± 0.62 | 2.51 ± 0.31 |
|
| 3.42 ± 0.28 | 7.63 ± 1.07 | 14.61 ± 1.11 | 0.86 ± 0.10 | 7.17 ± 0.58 | 6.99 ± 0.68 |
|
| 1.54 ± 0.18 | 0.83 ± 0.09 | 11.61 ± 1.09 | 0.88 ± 0.10 | 0.35 ± 0.05 | 1.36 ± 0.03 |
|
| 1.89 ± 0.23 | 1.00 ± 0.10 | 4.26 ± 0.50 | 0.52 ± 0.05 | 2.25 ± 0.26 | 2.58 ± 0.34 |
|
| 3.08 ± 0.32 | 1.81 ± 0.25 | 30.88 ± 3.51 | 3.80 ± 0.32 | 2.75 ± 0.22 | 4.25 ± 0.45 |
Figure 1Representative HPLC-DAD (λ = 254 nm) chromatogram of Mammillaria pringlei stem extracts: 1—protocatechuic acid, 2—gentisic acid, 3—chlorogenic acid, 4—p-hydroxybenzoic acid, 5—caffeic acid, 6—sinapic acid.
Antiproliferative activity [IC50 (µg mL−1)] of Mammillaria sp. stem extracts (mg mL−1) as well as gentisic acid on cancer cells.
| HeLa | Jurkat | HT-29 | MCF-7 | HEK-293 | |
|---|---|---|---|---|---|
| Control | 6.5 ± 0.1 | 22.0 ± 0.9 | 118.05 ± 5.7 | 21.94 ± 0.9 | ˃200 |
|
| 20.2 ± 0.2 | 18.3 ± 1.1 | 68.25 ± 3.3 | 28.9 ± 1.3 | ˃200 |
|
| 11.6 ± 0.3 | 10.6 ± 0.5 | 49.10 ± 2.6 | 22.3 ± 1.1 | ˃200 |
|
| 168.57 ± 5.4 | 88.32 ± 3.3 | ˃200 | 56.1 ± 2.9 | ˃200 |
|
| 173.18 ± 9.2 | 96.87 ± 5.2 | ˃200 | 64.9 ± 3.1 | ˃200 |
|
| 195.35 ± 10.8 | 79.65 ± 3.7 | ˃200 | 57.25 ± 2.5 | ˃200 |
|
| 163.22 ± 9.2 | 94.75 ± 4.7 | ˃200 | 63.25 ± 3.5 | ˃200 |
|
| 36.8 ± 1.2 | 26.17 ± 2.1 | 85.22 ± 0.2 | 33.85 ± 2.7 | ˃200 |
| Gentisic acid | 5.8 ± 0.3 | 7.9 ± 0.5 | 25.85 ± 1.3 | 10.85± 1.2 | ˃200 |
| Vinblastine sulfate | 2.1 ± 0.09 | 0.1 ± 0.02 | 19.32 ± 1.4 | ‒ | 47.1 ± 1.3 |
| Taxol | ‒ | ‒ | ‒ | 0.08 ± 0.008 | ‒ |
Figure 2Apoptotic cell population (IC50) using flow cytometry.
DPPH and β-carotene bleaching acid of Mammillaria sp. stem extracts as well as gentisic acid.
| DPPH (IC50, µg mL−1) | β-Carotene-Bleaching Assay (IC50, µg mL−1) | FRAP (IC50, mM TEAC/g Extract) | |
|---|---|---|---|
|
| 9.2 ± 0.3c | 11.1 ± 0.5c | 13.6 ± 0.9e |
|
| 7.3 ± 0.2cd | 9.2 ± 0.1d | 11.7 ± 0.7e |
|
| 20.9 ± 0.8a | 26.0 ± 0.9a | 34.9 ± 2.5a |
|
| 19.5 ± 0.7ab | 24.1 ± 1.5a | 31.2 ± 1.1b |
|
| 20.6 ± 1.7ab | 25.9 ± 2.3a | 32.7 ± 2.3ab |
|
| 18.4 ± 1.1b | 21.5 ± 0.6b | 26.9 ± 1.8c |
|
| 10.8 ± 0.5c | 12.8 ± 1.1c | 15.3 ± 1.5d |
| Gentisic acid | 5.9 ± 0.3d | 7.5 ± 0.3d | 10.1 ± 1.3f |
| BHT | 2.8 ± 0.1e | 3.2 ± 0.1e | — |
| Trolox | — | — | 3.4 ± 0.1g |
Values with different letters within a column indicates significant differences (p = 0.05). TEAC: Trolox equivalents anti-oxidant.
Minimum inhibitory (MIC) and bactericidal concentration (MBC) of Mammillaria sp. stem extracts (mg mL−1) as well as gentisic and chlorogenic acids.
|
| 14579 | 27853 | clinical isolate | 35210 | 10240 | 6538 |
|
| 0.12 ± 0.01 | 0.20 ± 0.02 | 0.27 ± 0.02 | 0.23 ± 0.03 | 0.31 ± 0.02 | 0.27 ± 0.01 |
| 0.43 ± 0.03 | 0.57 ± 0.03 | 0.82 ± 0.04 | 0.49 ± 0.03 | 0.72 ± 0.04 | 0.73 ± 0.03 | |
|
| 0.15 ± 0.01 | 0.27 ± 0.02 | 0.29 ± 0.01 | 0.24 ± 0.02 | 0.37± 0.01 | 0.29 ± 0.03 |
| 0.49 ± 0.03 | 0.65 ± 0.03 | 0.95 ± 0.03 | 0.52 ± 0.03 | 0.88 ± 0.05 | 0.85 ± 0.05 | |
|
| 0.35 ± 0.02 | 0.64 ± 0.01 | 0.59 ± 0.01 | 0.49 ± 0.01 | 0.78 ± 0.03 | 2.21 ± 0.21 |
| 0.83 ± 0.04 | 2.83 ± 0.16 | 1.78 ± 0.19 | 1.53 ± 0.12 | 2.48 ± 0.16 | 6.42 ± 0.65 | |
|
| 0.13 ± 0.01 | 0.23 ± 0.01 | 0.32 ± 0.03 | 0.27 ± 0.01 | 0.23 ± 0.01 | 0.42 ± 0.03 |
| 0.37 ± 0.03 | 0.68± 0.09 | 1.12 ± 0.11 | 1.32 ± 0.05 | 0.65 ± 0.03 | 1.33 ± 0.11 | |
|
| 0.29 ± 0.01 | 0.89 ± 0.01 | 1.17 ± 0.02 | 0.56 ± 0.01 | 0.67 ± 0.03 | 1.98 ± 0.01 |
| 0.87 ± 0.05 | 3.20 ± 0.15 | 3.92 ± 0.12 | 2.82 ± 0.31 | 2.23 ± 0.13 | 6.54 ± 0.53 | |
|
| 0.36 ± 0.02 | 1.10 ± 0.07 | 1.20 ± 0. 10 | 1.25 ± 0.02 | 2.14 ± 0.21 | 1.19 ± 0.01 |
| 0.93 ± 0.03 | 5.56± 0.28 | 4.75 ± 0.21 | 4.74 ± 0.52 | 7.87 ± 0.54 | 3.38 ± 0.17 | |
|
| 0.17 ± 0.01 | 0.29 ± 0.02 | 0.35 ± 0.01 | 0.43 ± 0.01 | 0.35± 0.02 | 0.29± 0.03 |
| 0.48 ± 0.03 | 0.78 ± 0.03 | 1.14 ± 0.18 | 1.85 ± 0.18 | 0.91 ± 0.05 | 0.92 ± 0.03 | |
|
| N.D. | N.D. | N.D. | 23.20 ± 0.02 | N.D. | N.D. |
| N.D. | N.D. | N.D. | > 100 | N.D. | N.D. | |
|
| 0.13 ± 0.01 | 0.07 ± 0.01 | 0.15 ± 0.01 | 0.18 ± 0.03 | 0.21 ± 0.02 | 0.25± 0.01 |
| 0.35 ± 0.02 | 0.34 ± 0.03 | 0.37± 0.03 | 0.45 ± 0.05 | 0.63 ± 0.03 | 0.63 ± 0.03 | |
|
| 0.08 ± 0.01 | 0.07 ± 0.01 | 0.13 ± 0.01 | 0.11 ± 0.01 | 0.10 ± 0.01 | 0.15 ± 0.01 |
| 0.17 ± 0.01 | 0.15 ± 0.01 | 0.28 ± 0.03 | 0.23 ± 0.01 | 0.20 ± 0.02 | 0.32 ± 0.02 |
Bacillus cereus (ATCC 14579), Listeria monocytogenes (clinical isolate), Escherichia coli (ATCC 35210), Micrococcus flavus (ATCC 10240), Staphylococcus aureus (ATCC 6538), and Pseudomonas aeruginosa (ATCC 27853)